|
|
Issue 1, October 2001
Biological & Biomedical Sciences
Lysosomal
and Mitochondrial Changes Detected During TNF-a-Induced
Apoptosis in MCF-7 Human Breast Cancer Cells
Manuel Zea
Department of Biology and Molecular Biology, Montclair State University
Advisor: Reginald Halaby
Department of Biology and Molecular Biology, Montclair State University
Abstract
Breast cancer
is the second leading cause of cancer deaths in women. Many of the
currently available treatments for breast cancer are invasive and
non-specific, killing healthy cells as well as cancerous ones. It
would be desirable to develop therapies that can specifically kill
neoplastic cells. We used human breast carcinoma MCF-7 cells as a
model system for human breast cancer. To elucidate the cellular processes
by which MCF-7 cells activate the apoptotic machinery, we induced
cell death by treating the cells with the cytokine tumor necrosis
factor-a (TNF-a).
Although several reports by other laboratories have addressed the
ability of TNF-a to induce apoptosis in
MCF-7 cells, the mechanism by which the cytokine does so is not well
understood. In the present report, we monitored TNF-a-induced
apoptosis in MCF-7 cells by performing lysosomal and mitochondrial
assays. TNF-a caused an increase in acid
phosphatase-positive staining cells. These results provide evidence
that lysosomal enzymes, including acid phosphatase, localize to cytoplasmic
and nuclear regions of dying MCF-7 cells in response to treatment
with TNF-a. There was a statistically significant
difference in cell viability between control and experimental cells.
Specifically, our results data demonstrate that TNF-a-induced
apoptosis leads to impaired mitochondrial function.
Introduction
Breast cancer is a major health problem, being the second deadliest form of cancer in women, behind lung cancer. Great strides have been made in the diagnosis, research, and treatment of breast cancer. However, breast cancer cells that are resistant to radiation, anti-hormonal therapy, and chemotherapy are also resistant to apoptosis. Treatments with antiestrogens are hampered by the development of hormone-refractory disease or hormone resistance (Glinsky et al. 1997; Teixeira et al. 1995).
Apoptosis is a form of cell suicide that is accompanied by characteristic biochemical and morphological changes. It involves DNA fragmentation, cytoplasmic shrinkage, the formation of membrane-bound structures that contain pieces of organelles and cytosol, called apoptotic bodies (Kerr et al. 1972), and activation of lysosomal enzymes (Halaby et al. 1994). Apoptosis plays an important role during development, tissue homeostasis, and growth regulation of differentiated tissues and is now recognized as an important target for the development of novel therapies against diseases such as cancer and AIDS.
Lysosomes contain at least 40 hydrolytic enzymes that are active at acidic pH. These enzymes are implicated in the cell death that occurs during the physiological involution of the uterus (Woessner 1965), the prostate gland (Helminen et al. 1972), and the mammary gland (Helminen and Ericsson, 1968). Lysosomal hydrolases also initiate apoptosis in diverse model systems (Tata 1994; Roberts et al. 1997; Li et al. 1998; Shibata et al. 1998). Finally, lysosomal hydrolases induce apoptosis of breast tumors in mammary carcinomas in rodents (Anton and Brandes 1968; Ball et al. 1982; Beem et al. 1987). In particular, acid phosphatase is the marker enzyme for lysosomes (Pelletier and Novikoff 1972) and has been used to monitor cell death and cell lysis (Heryanto et al. 1977; Beem et al. 1987; Halaby et al. 1994; Halaby et al. 1997).
MCF-7 cells provide an excellent in vitro model system to study human breast cancer. This cell line was established from the pleural effusion of a patient who was diagnosed with adenocarcinoma of the breast (Soule et al. 1973). In addition, the MCF-7 line retains several characteristics of differentiated mammary epithelium including the ability to respond to estrogen via cytoplasmic estrogen receptors (Brandes and Hermonat 1983). Elevated plasma estrogen concentrations are implicated in inducing breast cancer (Gustafsson and Warner 2000; Munster et al. 2001).
We have previously shown that the activity and localization of acid phosphatase can be used to monitor apoptosis (Halaby et al. 1994; Halaby 2000) and that acid phosphatase histochemical staining is marked in biopsies of non-invasive breast cancer, such as ductal carcinoma in situ (Halaby et al. 2001). Furthermore, we have shown that an increase in acid phosphatase activity is amongst the earliest biochemical indicators of apoptosis in two diverse model systems: the labial gland of Manduca Sexta, rat mammary gland, and breast carcinomas (Halaby et al. 1994; Halaby 2001; Halaby et al. 2001). In this report we demonstrate that MCF-7 cells display morphological alterations that are indicative of apoptotic cells when exposed to tumor necrosis factor-a (TNF-a). TNF-a is a cytokine with a wide range of biological functions, including induction of apoptosis in human tumor cells (Sugarman et al. 1985; Fiers 1991). The lysosomal compartment expanded in TNF-a-treated cells, and the activity of acid phosphatase was significantly elevated in experimental cells. Moreover, we show that the execution of the cell death program by TNF-a in MCF-7 cells involves impairment of mitochondrial respiration. Our results indicate that further research is warranted to determine if the deliberate activation of lysosomal enzymes or compromising mitochondrial activity may lead to the death of breast cancer cells.
Methods and Materials
Cell Culture
The human breast cancer cell line MCF-7 was purchased from American
Type Culture Collection (Manassas, VA). The cells were routinely
maintained in a-Minimally Essential Media (aMEM; BioWhittaker, Walkersville,
MD) supplemented with 10 % fetal bovine serum (Gibco, Grand Island,
NY), 2 mM glutamine, penicillin (100 Units/mL), and streptomycin
(100 mg/mL) in a humidified chamber at
37°C in 5% CO2/95% O2. Cells were grown in
T-25 flasks (Gibco) to yield 5 X 106 cells/mL. Cells
were trypsinized, washed with phosphate buffered saline (PBS; 137
mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4×7H2O,
1.4 mM KH2PO4, pH 7.4), resuspended in aMEM,
and pooled.
Determination of Cell Viability
Cell viability was assessed using a mitochondrial function assay,
the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) reduction assay (Sigma, St. Louis, MO). Stock solutions of
MTT (5 mg/mL) were prepared in aMEM.
Dissolved MTT is converted to an insoluble purple formazan by cleavage
of the tetrazolium ring by dehydrogenase enzymes of living cells
(Mosmann 1983). MCF-7 cells (5 X 106 cells/mL) were seeded
in 6-well plates containing 2 mL/well of aMEM
and treated in the absence or presence of TNF-a
(1 ng/mL, 10 ng/mL, or 25 ng/mL) for 24 h at 37°C. After this incubation
period, MTT (0.2 mL) was added to each well and the cells were incubated
for 4 h at 37°C. The medium was then removed and the converted dye
was solubilized with the addition of acidic isopropanol (0.1 N HCl
in absolute isopropanol). Absorbance, which was proportional to
cell viability, was measured at 570 nm with background subtraction
at 660 nm.
Lysosomal Assay
To localize lysosomes in MCF-7 cells, a histochemical assay (Sigma
kit 181-A) for acid phosphatase was used. The p-nitrophenol
phosphate (substrate) stock solution was prepared by dissolving
a 100 mg capsule in 25 ml dH2O. The stock solution was dispensed
in 0.5 ml aliquots and stored at -20°C. The cells (5 X 106
cells/mL) were grown on tissue culture treated microscope glass
cover slides (Fisher Scientific, Pittsburgh, PA), which were submerged
in 6-well plates that contained 2 mL/well aMEM.
Cells were allowed to attach to the slides overnight and were treated
with or without TNF-a (1 ng/mL) for 24
h at 37°C. Prior to fixation, 0.6 mL sodium nitrite solution were
added to 0.6 mL fast garnet GBC solution, mixed by inversion; allowed
to stand 2-4 min; and added to 23 mL dH2O. Three mL acetate
solution and 3 mL naphthol AS-BI phosphoric acid solution were added
to the previous solution and mixed well. Slides were fixed in a
citrate-acetone-formaldehyde solution at room temperature, in Coplin
jars for 30 sec, and rinsed with dH2O for 1 min. Slides
were then incubated for 1 h at 37°C in naphthol AS-BI phosphate
and fast garnet stain in acetate buffer. Slides were rinsed with
tap H2O for 2 min, dried for 15 min in a fume hood, counterstained
with methylene blue for 1 min, rinsed with dH2O, and
mounted in CrystalMount (Biomeda Corp., Foster City, CA). The presence
of acid phosphatase was indicated by distinct focal precipitates,
which were resolved by light microscopy.
Statistical Analysis
A student's t-test was used for the determination of statistical
significance. Absorbance values for TNF-a-treated and control cells
were considered statistically different at p < 0.05.
Results
Mitochondrial Function
Mitochondrial dehydrogenases from living cells are able to convert
soluble MTT to an insoluble formazan via a reduction reaction. We
show by MTT assay (mitochondrial activity) that TNF-a
is cytotoxic to MCF-7 cells. The optical density of the converted
dye is measured spectrophotometrically. The cell viability of control
cells was significantly higher than that of TNF-a-treated
cells (Fig. 1). TNF-a killed MCF-7 cells in
a dose-dependent fashion. Statistically significant differences
were observed between cell viability in experimental cells relative
to control cells at all three concentrations of TNF-a
(Fig. 1). In increasing concentration order, the values were p <
0.02, p < 0.003, and p < 0.03. This indicates that mitochondrial
respiration can be used to quantitate apoptosis in MCF-7 cells that
are exposed to TNF-a. The control cells stained
more intensely with MTT, indicating that the majority of mitochondria
possessed functional enzymes, while the experimental cells did not
(data not shown).

Figure 1. Effect of Various Concentrations of TNF on the Viability
of MCF7 Cells. Cell viability was determined by the MTT reduction
assay as described Materials and Methods. Cells (5 X 106/ mL) were
treated with different 1, 10, or 25 ng/mL of TNF for 24 h at 37
°C in a CO2 incubator. The values represent means plus SEM of at
least three separate experiments. Asterisks indicate statistically
different values in experimental cells compared to control cells
(at 1 ng/mL, p < 0.02; at 10 ng/mL, p < 0.003; and at 25 ng/mL,
p < 0.03). All determinations were made in triplicate. These results
suggest that TNF kills MCF7 cells in a dose-dependent manner by
compromising mitochondrial function.
Lysosomal Assay
Lysosomes contain digestive enzymes that can degrade all macromolecules:
proteins, nucleic acids, lipids, and carbohydrates. Consequently lysosomal
enzyme degradation, when triggered by an appropriate signal, such
as 20-hydroxyecdysone in apoptosis of insect tissues (Halaby et
al. 2000) or by hormone ablation in apoptosis of the rat mammary
gland (Halaby 2001), can lead to the demise of the aforementioned
tissues. TNF-a-treated MCF-7 cells displayed intense and diffuse positive
histochemical staining for acid phosphatase, which is specific for
lysosomes, mostly in the cytoplasm (Fig. 2 c and d). Positive acid
phosphatase staining was also detected in the nuclei of some cells
(Fig. 2 d). Lysosomes were larger and more numerous in TNF-a-treated
cells compared to control cells. Cell shrinkage, a characteristic
of apoptotic cells, presumably due to alterations of the cytoskeleton
(Halaby et al. 2000), was observed in experimental cells (Fig.
2 c), but was not apparent in control cells (Fig. 2 a and b). These
results suggest that there is an increase in lysosomal enzyme activity
and staining intensity in MCF-7 cells in response to TNF-a.
Figure 2. Histochemical Localization of Acid Phosphatase in MCF7
Cells. MCF7 cells were treated in the absence (panels a & b)
or in the presence of TNF (panels c & d) as described in Materials
and Methods. Very faint staining for acid phosphatase is detectable
in control cells (panels a & b), however there is intense positive
staining for acid phosphatase throughout the cytoplasm of TNF-treated
cells (panels c & d). Acid phosphatase was also present in the nuclei
of some cells (panel d). Magnification: panels a & c, 250 X; panels
b & d, 600 X.
Discussion
Apoptosis is a genetically controlled form of cell death that is conserved
from worms to humans (Steller 1995). A diverse set of stimuli can
trigger the apoptotic process in virtually all eukaryotic cells (Steller
1995; Thompson 1995). Inappropriate or insufficient apoptotic cell
death is known to play a role in a variety of diseases including Alzheimer's
disease, Parkinson's disease, stroke, lupus, AIDS, and cancer (Thompson
1995). Cancer cells are known to be resistant to apoptosis. The mechanisms
underlying this resistance, however, remain unclear. MCF-7 cells retain
many cellular receptors and other characteristics, as do human breast
cancer cells in vivo. Thus, these cells provide one with an ideal
opportunity to dissect and elucidate the processes that regulate the
resistance of breast cancer cells to chemotherapy and radiation.
The mitochondrial activity assay, MTT, is one of the few assays used
to monitor apoptosis that provides quantitative rather than qualitative
results. We show that reduction of MTT in MCF-7 cells was significantly
impaired by TNF-a. This result is consistent
with reports from other laboratories that perform the MTT assay after
treating MCF-7 cells with various drugs designed to induce apoptosis
(Rodgers and Grant 1998). TNF-a induces
apoptosis by recruitment of mitochondrial pathways to apoptosis (Thomas
et al. 2000). In addition, TNF-a
was shown to trigger apoptosis by causing a partial decrease in mitochondrial
membrane potential in sensitive cells (Gottlieb et al. 2000).
Taken together, these results support our contention that TNF-a-induced
apoptosis of MCF-7 cells leads to impaired mitochondrial function.
Lysosomal enzymes have been studied extensively in breast cancer cells
(Capony et al. 1990; Montcourrier et al. 1990; Rochefort
et al. 1987; Halaby et al. 2001). These studies, however,
focused on utilizing the enzymes to predict a patient's prognosis
or to determine when breast cancer cells acquire the ability to become
metastatic. In contrast, our report is the first of its kind to employ
the identification of lysosomes to monitor apoptosis in MCF-7 cells.
We have used lysosomal enzymes to quantitate apoptosis in rat mammary
glands that were induced to undergo cell death via weaning (Halaby
2001). This is a very sensitive, efficient, and specific marker for
cell death. We are currently investigating whether various signaling
molecules, besides TNF-a, can orchestrate
similar mitochondrial and lysosomal changes in MCF-7 cells during
apoptosis.
References
Anton, E., D. Brandes. (1968) Lysosomes in mice mammary tumors treated with cyclophosphamide. Distribution related to course of disease. Cancer 21:483-500.
Ball, A., G.M. Barratt, E.D. Wills. (1982) Activation of lysosomal enzymes and tumour regression caused by irradiation and steroid hormones. Eur J Cancer Clin Oncol 18:489-494.
Beem, E.P., M.J. Hillebrand, C. Benckhuijsen, B. Overdijk. (1987) Origin of the increased activity of beta-glucuronidase in the soluble fraction of rat mammary tumors during ovariectomy-induced regression. Cancer Res 47:3980-3987.
Bogin, L., M.Z. Papa, S. Polak-Charcon, H. Degani. (1998) TNF-A-induced modulations of phospholipid metabolism in human breast cancer cells. Biochim Biophys Acta 1392:217-32
Brandes, D., E. Anton. (1966) The role of lysosomes in cellular lytic processes. 3. Electron histochemical changes in mammary tumors after treatment with cytoxan and vitamin A. Lab Invest 15:987-1006.
Brandes, L.J., M.W. Hermonat. (1983) Receptor status and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol. Cancer Res 43:2831-2835.
Capony, F., C. Rougeot, V. Cavailles, H. Rochefort. (1990) Estradiol increases the secretion by MCF-7 cells of several lysosomal pro-enzymes. Biochem Biophys Res Commun 171:972-978.
Fiers, W. (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 285:199-212.
Glinsky, G.V., V.V. Glinsky, A.B. Ivanova, C.J. Hueser. (1997) Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett 115:185-193.
Gottlieb, E., M.G. Vander Heiden, C.B. Thompson. (2000) Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 20:5680-5689.
Gustafsson, J.A., M. Warner. (2000) Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J Steroid Biochem Mol Biol 74:245-248.
Halaby, R., J. Abdollahi, M.L. Martinez. (2001). Acid phosphatase activity in human breast tumors. Breast Cancer Res 3:E002.
Halaby, R. (2001). Mammary gland cell death also involves lysosomal autophagy. Breast Cancer Res 3:E003.
Halaby, R., S. Ziaei, Z. Zakeri. (2000). Cytoskeletal alterations occur in the labial gland of Manduca Sexta during apoptosis. Lepidoptera J 4:6-14.
Halaby, R. (1997). Hormonal regulation of programmed cell death in the labial gland of the tobacco hornworm, Manduca Sexta. Ph.D. Dissertation, The City University of New York.
Halaby, R., Z. Zakeri, R.A. Lockshin. (1994) Metabolic events during programmed cell death in insect labial glands. Biochem Cell Biol 72:597-601.
Helminen, H.J., J..L Ericsson, B. Arborgh. (1972) Differing patterns of acid phosphatase and cathepsin D activities in the rat ventral prostate gland during castration-induced prostatic involution. Acta Endocrinol 69:747-761.
Helminen, H.J., J.L. Ericsson, S. Orrenius. (1968) Studies on mammary gland involution. IV. Histochemical and biochemical observations on alterations in lysosomes and lysosomal enzymes. J Ultrastruct Res 25:240-252.
Heryanto, B., Y. Yoshimura, T. Tamura, T. Okamoto. (1977) Involvement of apoptosis and lysosomal hydrolase activity in the oviducal regression. during induced molting in chickens: a cytochemical study for end labeling of fragmented DNA and acid phosphatase. Poult Sci J 76:67-72.
Kerr, J.F.R., A.H. Wyllie, A.R. Currie. (1972) Apoptosis: a basic biological phenomenon with wide range implications in tissue kinetics. Br J Cancer 26:239-257.
Li, W., X.M. Yuan, U.T. Brunk. (1998) OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. Free Radic Res 29:389-398.
Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
Montcourrier, P., P.H. Mangeat, G. Salazar, M. Morisset, A. Sahuquet, H. Rochefort. (1990) Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res 50:6045-6054.
Munster, P.N., A. Buzdar, K. Dhingra, N. Enas, L. Ni, M. Major, A. Melemed, A. Seidman, D. Booser, R. Theriault, L. Norton, C. Hudis. (2001) Phase i study of a third-generation selective estrogen receptor modulator, ly353381.hcl, in metastatic breast cancer. J Clin Oncol 19:2002-2009.
Pelletier, G., A.B. Novikoff. (1972) Localization of phosphatase activities in the rat anterior pituitary gland. J Histochem Cytochem 1972, 20:1-12.
Roberts, L.R., H. Kurosawa, S.F. Bronk, P.J. Fesmier, L.B. Agellon, W.Y. Leung, F. Mao, G.J. Gores. (1997) Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 113:1714-1726.
Rochefort H., F. Capony, P. Augereau, V. Cavailles, M. Garcia, M. Morisset, G. Freiss, T. Maudelonde, F. Vignon. (1987) The estrogen-regulated 52K-cathepsin-D in breast cancer: from biology to clinical applications. Int J Rad Appl Instrum B 114:377-384.
Rodgers EH, M.H. Grant. (1998) The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF-7 human breast cancer cells. Chem Biol Interact 116:213-228.
Shibata, M., S. Kanamori, K. Isahara, Y. Ohsawa, A. Konishi, S. Kametaka, T. Watanabe, S. Ebisu, K. Ishido, E. Kominami, Y. Uchiyama. (1998) Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem Biophys Res Commun 251:199-203.
Soule, H.D., J. Vazguez, A. Long, S. Albert, M. Brennan. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409-1416.
Steller, H. (1995) Mechanisms and genes of cellular suicide. Science 267:1445-1449.
Sugarman, B.J., B.B. Aggarwal, P.E. Hass, I.S. Figari, M.A. Palladino Jr, H.M. Shepard. (1985) Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science. 230:943-945.
Tata, J.R. (1994) Hormonal regulation of programmed cell death during amphibian metamorphosis. Biochem Cell Biol 72:581-588.
Teixeira, C., J.C. Reed, M.A. Pratt. (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55:3902-3907.
Thomas, W.D., X.D. Zhang, A.V. Franco, T. Nguyen, P. Hersey. (2000) TNF-a-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria. J Immunol 165:5612-5620.
Thompson, C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456-1462.
Woessner, J.F. Jr. (1965) Acid hydrolases of the rat uterus in relation to pregnancy, post-partuminvolution and collagen breakdown. Biochem J 97:855-866.
Journal of Young
Investigators. 2001. Volume Five.
Copyright © 2001 by Manuel Zea and JYI. All rights reserved. |
|